Search Press releases Keywords From To 1 Feb 2012 UCB and Astellas announce agreement to jointly develop and commercialize Cimzia® (certolizumab pegol) in Japan Read More 27 Jan 2012 Transparency Notification of Wellington management Company LLP Read More 26 Jan 2012 Acquisition of own shares in the framework of employees’ long-term incentive plans Read More 25 Jan 2012 UCB announces FDA approval for Keppra® in infants and children from one month of age with partial onset seizures Read More 23 Jan 2012 NYSE Euronext Brussels grants UCB the Best BEL 20 Performer Award 2011 Read More 19 Jan 2012 Acquisition of own shares in the framework of employees’ long-term incentive plans Read More Pagination First page Previous page Previous … Page 131 Page 132 Page 133 Page 134 Current page 135 Page 136 Page 137 Page 138 Page 139 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
